A Study of Olaparib and Low Dose Radiotherapy for Small Cell Lung Cancer

NCT03532880 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

26

Enrollment

OTHER

Sponsor class

Conditions

Small-cell Lung Cancer
Small Cell Lung Carcinoma

Interventions

DRUG: Olaparib Pill 50 mg
DRUG: Olaparib Pill 100 mg
DRUG: Olaparib Pill 150 mg
DRUG: Olaparib Pill 200 mg
DRUG: Olaparib Pill 250 mg
DRUG: Olaparib Pill 300 mg
RADIATION: Radiotherapy

Sponsor

Memorial Sloan Kettering Cancer Center